Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas 01/08/2020 Health Problems
First study of neoadjuvant use of PARP inhibitor shows promise for early-stage, BRCA+ breast cancer patients 06/04/2018 Health Problems
